The federal contract IDV award W81K0220D0003 is a single-award indefinite delivery contract held by Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, valued up to $649,470, is with the Defense Health Agency to provide VENTANA HE600 reagents - critical consumables used in immunohistochemistry staining platforms - to support military healthcare and biological defense programs at U.S. military medical facilities in South Korea.
To date, five firm-fixed-price delivery orders totaling $204,456 have been issued against this IDV contract, with the most recent award of $10,267 made in April 2024. The contract has no set-aside designation, indicating open competition. Inseonmedics Inc. has functioned as the prime contractor, supplying specialized laboratory reagents and equipment compatible with the VENTANA HE600 platform to maintain testing capabilities at facilities such as the Brian D. Allgood Army Community Hospital and Biological Defense Automated Analytical Platform in South Korea. The original pre-solicitation sought a vendor capable of providing a range of VENTANA HE600 reagents, highlighting the importance of these supplies for supporting military medical and biological defense operations in the region.
Generated 2/27/25, 10:25 AM